What question did this study set out to answer?

To examine the FDA's experience with extrapolating adult efficacy data to pediatric drug development, evaluating its frequency, changes over time, and effect on pediatric labeling.

October 25, 2011PEDIATRICS

Extrapolation of Adult Data and Other Data in Pediatric Drug-Development Programs

View Full Paper

Ask AI

Bookmark

To examine the FDA's experience with extrapolating adult efficacy data to pediatric drug development, evaluating its frequency, changes over time, and effect on pediatric labeling.
Reviewed 370 pediatric studies submitted to the FDA between 1998 and 2008 in response to 159 written requests covering 166 drug products under the Pediatric Exclusivity Provision.
Categorized cases by the degree of efficacy extrapolation required (complete vs. partial) and evaluated whether submissions achieved new pediatric labeling.
Efficacy was extrapolated from adult data in 82.5% of drug products (137 of 166), with 14.5% (24 of 166) categorized as complete and 68% (113 of 166) as partial extrapolation.
Extrapolation approaches shifted over time in 19% of the therapeutic indications studied (13 of 67).
Drug products using extrapolation achieved a new pediatric indication or age extension in 61% of cases (84 of 137), compared to 34% (10 of 29) when no extrapolation was used.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Regulatory review reveals higher pediatric drug approval rates when extrapolating adult efficacy data, indicating a streamlined path for pediatric medicine labeling.

Cite This Study

Dunne et al. (2011) studied this question.

synapsesocial.com/papers/6a7caab364c599404428a6fe https://doi.org/10.1542/peds.2010-3487

View Full Paper

Ask AI

Bookmark

Implication

Regulatory review reveals higher pediatric drug approval rates when extrapolating adult efficacy data, indicating a streamlined path for pediatric medicine labeling.

Extrapolation of Adult Data and Other Data in Pediatric Drug-Development Programs

Key Points

Discussion

Implication

Cite This Study

Extrapolation of Adult Data and Other Data in Pediatric Drug-Development Programs

Key Points

Discussion

Implication

Cite This Study

Keep reading

Keep reading